WUHN WEBINAR ON : Welcome to the Future of Personalized Medicine for Mental Illness
Newly appointed Chief Innovation Officer of M2Bio Sciences, Dr. Riyad Domingo, will be presenting his inaugural webinar on the future of mental health therapeutics derived from the psychedelic prodrug psilocybin.
He will provide an overview of the company's innovative work leveraging the power of artificial intelligence and additive manufacturing in the drug discovery and development process.
Welcome to the future of personalized medicine for mental illness.
He will provide an overview of the company's innovative work leveraging the power of artificial intelligence and additive manufacturing in the drug discovery and development process.
"We are thrilled to share our upcoming webinar October 1st, 2021 at 3 pm South Africa time. For three years the M2bio science team has focused on the science, research and development of psilocybin therapies. Our time has come to share our vision for what we see as being the next generation for drug discovery for mental health therapeutics derived from the psychedelic prodrug psilocybin.'' - said Jeff Robinson, CEO of M2Bio Sciences.
Welcome to the future of personalized medicine for mental illness.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.